Market revenue in 2024 | USD 16.7 million |
Market revenue in 2030 | USD 20.4 million |
Growth rate | 3.3% (CAGR from 2025 to 2030) |
Largest segment | Metal |
Fastest growing segment | Metal |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Polymer, Metal |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Cardinal Health Inc, BIOTRONIK, Meril Life, Abbott Laboratories, Elixirr International PLC Ordinary Shares, REVA Medical, Anteris Technologies Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bioresorbable coronary stents market will help companies and investors design strategic landscapes.
Metal was the largest segment with a revenue share of 52.1% in 2024. Horizon Databook has segmented the UK bioresorbable coronary stents market based on polymer, metal covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the UK bioresorbable coronary stents market, including forecasts for subscribers. This country databook contains high-level insights into UK bioresorbable coronary stents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account